{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T11:30:11Z","timestamp":1703158211257},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2006,1,19]],"date-time":"2006-01-19T00:00:00Z","timestamp":1137628800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1007\/s10461-005-9048-4","type":"journal-article","created":{"date-parts":[[2006,1,18]],"date-time":"2006-01-18T21:30:11Z","timestamp":1137619811000},"page":"273-277","source":"Crossref","is-referenced-by-count":5,"title":["Lipodystrophy Severity Does Not Contribute to HAART Nonadherence"],"prefix":"10.1007","volume":"10","author":[{"given":"Evan J.","family":"Collins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert W.","family":"Burgoyne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl A.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan E.","family":"Abbey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark H.","family":"Halman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret L.","family":"Nur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon L.","family":"Walmsley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,1,19]]},"reference":[{"key":"9048_CR1","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1097\/00126334-200212153-00011","volume":"31","author":"A. Ammassari","year":"2002","unstructured":"Ammassari, A., Antinori, A., Cozzi-Lepri, A., Trotta, M. P., Nasti, G., Ridolfo, A. L., Mazzotta, F., Wu, A. W., D'Arminio Monforte, A., and Galli, M. (2002a). Relationship between HAART adherence and adipose tissue alterations. Journal of Acquired Immune Deficiency Syndromes, 31, S140\u2013S144.","journal-title":"Journal of Acquired Immune Deficiency Syndromes,"},{"key":"9048_CR2","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/00042560-200112150-00006","volume":"28","author":"A. Ammassari","year":"2001","unstructured":"Ammassari, A., Murri, R., Pezzotti, P., Trotta, M. P., Ravasio, L., De Longis, P., Lo Caputo, S., Narciso, P., Pauluzzi, S., Carosi, G., Nappa, S., Piano, P., Izzo, C. M., Lichtner, M., Rezza, G., Monforte, A., Ippolito, G., D'Arminio Moroni, M., Wu, A. W., and Antinori, A. (2001). Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. Journal of Acquired Immune Deficiency Syndromes, 28, 445\u2013449.","journal-title":"Journal of Acquired Immune Deficiency Syndromes,"},{"key":"9048_CR3","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1097\/00126334-200212153-00007","volume":"31","author":"A. Ammassari","year":"2002","unstructured":"Ammassari, A., Trotta, M. P., Murri, R., Castelli, F., Narciso, P., Noto, P., Vecchiet, J., D'Arminio Monforte, A., Wu, A. W., and Antinori, A. (2002b). Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature. Journal of Acquired Immune Deficiency Syndromes, 31, S123\u2013S127.","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"9048_CR4","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/00126334-200202011-00002","volume":"29","author":"J. A. Bartlett","year":"2002","unstructured":"Bartlett, J. A. (2002). Addressing the challenges of adherence. Journal of Acquired Immune Deficiency Syndromes, 29, S2\u2013S10.","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"9048_CR5","first-page":"114","volume":"21","author":"S. Bassetti","year":"1999","unstructured":"Bassetti, S., Battegay, M., Furrer, H., Rickenback, M., Flepp, M., Kaiser, L., Telenti, A., Vernazza, P. L., Bernasconi, E., and Sudre, P. (1999). Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Journal of Acquired Immune Deficiency Syndromes, 21, 114\u2013119.","journal-title":"Journal of Acquired Immune Deficiency Syndromes,"},{"key":"9048_CR6","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","volume":"12","author":"A. Carr","year":"1998","unstructured":"Carr, A., Samaras, K., Burton, S., Law, M., Freund, J., Chisholm, D., and Cooper, D. A. (1998). A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS, 12, F51\u2013F58.","journal-title":"AIDS"},{"key":"9048_CR7","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","volume":"353","author":"A. Carr","year":"1999","unstructured":"Carr, A., Samaras, K., Thorisdottir, A., Kaufmann, G., Chisholm, D., and Cooper, D. (1999). Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia and diabetes mellitus: A cohort study. Lancet, 353, 2093\u20132099.","journal-title":"Lancet,"},{"key":"9048_CR8","first-page":"546","volume":"10","author":"E. J. Collins","year":"2000","unstructured":"Collins, E. J., Wagner, C. A., and Walmsley, S. L. (2000). Psychosocial impact of the lipodystrophy syndrome in HIV infection. AIDS Reader, 10, 546\u2013550.","journal-title":"AIDS Reader,"},{"key":"9048_CR9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF02850110","volume":"18","author":"R. A. DeMasi","year":"2001","unstructured":"DeMasi, R. A., Graham, N. M., Tolson, J. M., Pham, S. V., Capuano, G. A., Fisher, R. L., Shaefer, M. S., Pakes, G. E., Sawyerr, G. A., and Eron, J. J. (2001). Correlation between self-reported adherence to highly active antiretroviral therapy (HAART) and virologic outcome. Advances in Therapy, 18, 163\u2013173.","journal-title":"Advances in Therapy,"},{"key":"9048_CR10","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1097\/00002030-200112070-00012","volume":"15","author":"S. Duran","year":"2001","unstructured":"Duran, S., Saves, M., Spire, B., Cailleton, V., Sobel, A., Carrieri, P., Salmon, D., Moatti, J. P., and Leport, C. (2001a). Failure to maintain long-term adherence to highly active antiretroviral therapy: The role of lipodystrophy. AIDS, 15, 2441\u20132444.","journal-title":"AIDS,"},{"key":"9048_CR11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1310\/R8M7-EQ0M-CNPW-39FC","volume":"2","author":"S. Duran","year":"2001","unstructured":"Duran, S., Spire, B., Raffi, F., Walter, V., Bouhour, D., Journot, V., Cailleton, V., Leport, C., and Moatti, J. P. (2001b). Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART. HIV Clinical Trials, 2, 38\u201345.","journal-title":"HIV Clinical Trials,"},{"key":"9048_CR12","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/0954012021000005434","volume":"14","author":"T. F. Ferguson","year":"2002","unstructured":"Ferguson, T. F., Stewart, K. E., Funkhouser, E., Tolson, J., Westfall, A. O., and Saag, M. S. (2002). Patient-perceived barriers to antiretroviral adherence: Associations with race. AIDS Care, 14, 607\u2013617.","journal-title":"AIDS Care"},{"key":"9048_CR13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1468-1293.2003.00147.x","volume":"4","author":"O. W. Fong","year":"2003","unstructured":"Fong, O. W., Ho, C. F., Fung, L. Y., Lee, F. K., Tse, W. H., Yuen, C. Y., Sin, K. P., and Wong, K. H. (2003). Determinants of adherence to highly active antiretroviral therapy (HAART) in Chinese HIV\/AIDS patients. HIV Medicine, 4, 133\u2013138.","journal-title":"HIV Medicine"},{"key":"9048_CR14","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/00126334-200004150-00005","volume":"23","author":"A. L. Gifford","year":"2000","unstructured":"Gifford, A. L., Bormann, J. E., Shively, M. J., Wright, B. C., Richman, D. D., and Bozzette, S. A. (2000). Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. Journal of Acquired Immune Deficiency Syndromes, 23, 386\u2013395.","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"9048_CR15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1310\/W1QF-C9X9-9PFT-88JK","volume":"4","author":"G. Guaraldi","year":"2003","unstructured":"Guaraldi, G., Murri, R., Orlando, G., Orlandi, E., Sterrantino, G., Borderi, M., Grosso, C., Cattelan, M. A., Nardini, G., Beghetto, B., Antinori, A., Esposito, R., and Wu, A. W. (2003). Morphologic alterations in HIV-infected people with lipodystrophy are associated with good adherence to HAART. HIV Clinical Trials, 4, 99\u2013106.","journal-title":"HIV Clinical Trials,"},{"key":"9048_CR16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00002030-200101260-00013","volume":"15","author":"K. V. Heath","year":"2001","unstructured":"Heath, K. V., Hogg, R. S., Chan, K. J., Harris, M., Montessori, V., O'Shaugnessy, M. V., and Montaner, J. S. (2001). Lipodystrophy-associated morphological, cholesterol and triglyceride abnormalities in a population-based HIV\/AIDS treatment database. AIDS, 15, 231\u2013239.","journal-title":"AIDS"},{"key":"9048_CR17","unstructured":"Jhingran, P., Tolson, J., Scott-Lennox, J., Jordan, J., and Pham, S. (1997). Development and content validation of an HIV-specific Patient Medication Adherence Questionnaire (PMAQ). Paper presented at the 37th Interscience Conference on Anti-Microbrial Agents Chemotherapy, Toronto, Canada."},{"key":"9048_CR18","first-page":"126","volume":"21","author":"A. C. Justice","year":"1999","unstructured":"Justice, A. C., Rabeneck, L., Hays, R. D., Wu, A. W., and Bozzette, S. A. (1999). Sensitivity, specificity, reliability, and clinical validity of provider-reported symptoms: A comparison with self-reported symptoms. Journal of Acquired Immune Deficiency Syndromes, 21, 126\u2013133.","journal-title":"Journal of Acquired Immune Deficiency Syndromes,"},{"issue":"Suppl 4","key":"9048_CR19","first-page":"S62","volume":"12","author":"B. McCarron","year":"1998","unstructured":"McCarron, B., Pithie, C., and Mathers, L. (1998). Adherence to anti-retroviral therapy in Glasgow HIV patients. AIDS, 12(Suppl 4), S62. Abstract P181.","journal-title":"AIDS"},{"key":"9048_CR20","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1086\/344055","volume":"35","author":"N. I. Paton","year":"2002","unstructured":"Paton, N. I., Earnest, A., Ng, Y. M., Karim, F., and Aboulhab, J. (2002). Lipodystrophy in a cohort of human immunodeficiency virus-infected Asian patients: Prevalence, associated factors and psychological impact. Clinical Infectious Diseases, 35, 1244\u20131249.","journal-title":"Clinical Infectious Diseases,"},{"key":"9048_CR21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0753-3322(99)80063-8","volume":"53","author":"R. W. Shafer","year":"1999","unstructured":"Shafer, R. W., and Vuitton, D. A. (1999). Highly active antiretroviral therapy (HAART) for the treatment of infection with human immunodeficiency virus type 1. Biomedicine and Pharmacotherapy, 53, 73\u201386.","journal-title":"Biomedicine and Pharmacotherapy"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-005-9048-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10461-005-9048-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-005-9048-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T17:27:22Z","timestamp":1559150842000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10461-005-9048-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,19]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["9048"],"URL":"https:\/\/doi.org\/10.1007\/s10461-005-9048-4","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1,19]]}}}